{"nctId":"NCT02158806","briefTitle":"Low Dose Aspirin for Venous Leg Ulcers","startDateStruct":{"date":"2015-03"},"conditions":["Venous Leg Ulcer"],"count":251,"armGroups":[{"label":"Aspirin","type":"EXPERIMENTAL","interventionNames":["Drug: Aspirin"]},{"label":"Inert capsule","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Aspirin","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Aged 18 years or older\n* Determined to have a venous leg ulcer (clinical indications of venous ulceration, Ankle Brachial Index â‰¥ 0.8, and other causative aetiologies ruled out)\n* Able to tolerate compression therapy\n* Able to provide written informed consent\n* Confirmation with participant's general practitioner that the participant can take low dose aspirin or placebo.\n\nExclusion Criteria:\n\n* Pregnant or breast-feeding women\n* History of myocardial infarction, stroke, transient ischaemic attack, angina or significant peripheral arterial disease\n* History of adverse effects related to aspirin use\n* Currently using aspirin, or other anti-platelet or anticoagulant therapy\n* Opinion of screening medical practitioner at National Institute of Health Innovation that participant has an existing condition or treatment that is a contraindication to use of aspirin or to participation in the trial.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Time to Complete Healing of Reference Ulcer","description":"Time to event (complete healing defined as intact skin with absence of scab)","paramType":"MEDIAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"77","spread":null},{"groupId":"OG001","value":"69","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Healed Venous Leg Ulcers","description":"Number of participants in each arm with completely healed reference ulcers at 24 weeks","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"88","spread":null},{"groupId":"OG001","value":"101","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Estimated Ulcer Area","description":"Change in estimated ulcer area from baseline to 24 weeks","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.1","spread":"0.4"},{"groupId":"OG001","value":"4.8","spread":"0.4"}]}]}]},{"type":"SECONDARY","title":"Change in Health-related Quality of Life (Short Form 36)","description":"Mean difference in change in Short Form 36 (SF36) from baseline to 24 weeks. Crude subscale scores for each group are not shown (each crude subscale is scored 0 to 100 at baseline and 24 weeks); higher mean differences in change from baseline to 24 weeks within groups indicate greater change on the subscales for that group.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.0","spread":"2.2"},{"groupId":"OG001","value":"3.8","spread":"2.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.7","spread":"3.4"},{"groupId":"OG001","value":"10.3","spread":"3.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.4","spread":"2.2"},{"groupId":"OG001","value":"9.0","spread":"2.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.1","spread":"1.4"},{"groupId":"OG001","value":"-0.8","spread":"1.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.9","spread":"1.6"},{"groupId":"OG001","value":"-0.3","spread":"1.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.8","spread":"2.2"},{"groupId":"OG001","value":"4.9","spread":"2.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.5","spread":"3.1"},{"groupId":"OG001","value":"6.8","spread":"3.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.2","spread":"1.4"},{"groupId":"OG001","value":"1.2","spread":"1.4"}]}]}]},{"type":"SECONDARY","title":"Change in Health-related Quality of Life (EuroQol-5D 3L)","description":"Mean difference in change measured by EuroQol 5D (EQ5D 3L) from baseline to 24 weeks. Crude health state scores for each group are not shown (health state is scored 0 to 100 at baseline and 24 weeks); higher mean differences in change from baseline to 24 weeks within groups indicate greater change on health state for that group.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.4","spread":"1.6"},{"groupId":"OG001","value":"4.0","spread":"1.7"}]}]}]},{"type":"SECONDARY","title":"Change in Health-related Quality of Life (Charing Cross Venous Ulcer Questionnaire)","description":"Mean difference in change in Charing Cross Venous Ulcer Questionnaire (CXVUQ)) from baseline to 24 weeks. Crude subscale scores for each group are not shown (each crude subscale is scored 0 to 100 at baseline and 24 weeks); higher mean differences in change from baseline to 24 weeks within groups indicate greater change on the subscales for that group.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.2","spread":"1.3"},{"groupId":"OG001","value":"-4.7","spread":"1.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.6","spread":"1.1"},{"groupId":"OG001","value":"-5.2","spread":"1.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.1","spread":"1.6"},{"groupId":"OG001","value":"-4.9","spread":"1.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-9.4","spread":"1.8"},{"groupId":"OG001","value":"-6.5","spread":"1.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.3","spread":"1.2"},{"groupId":"OG001","value":"-5.5","spread":"1.2"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Adherence to Treatment","description":"Adherence to study medication as measured by pill counts (agreement between expected number of tablets remaining after healing and days to healing)","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"92","spread":null},{"groupId":"OG001","value":"92","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of Adverse Events at 24 Weeks","description":"Total number of different types of adverse events in participants who reported with any untoward medical event","paramType":"COUNT_OF_UNITS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"4","spread":null}]},{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"4","spread":null}]},{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"5","spread":null}]},{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"4","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"5","spread":null}]},{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"2","spread":null}]},{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"4","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null}]},{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"3","spread":null}]},{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":11,"n":125},"commonTop":["Laceration and contusions","Bleeding from any lower leg ulceration","Infection of ulceration, any lower leg ulceration","Developed any new lower leg ulceration","Extension of reference ulceration"]}}}